Success Story: EB2 NIW Approval for a Chemistry Visiting Professor in less than 5 months
Client’s testimonial:
You[r] news made us [so] happy, I greatly appreciate for what you did for us.
On June 17th, 2013, we received another EB2 NIW (National Interest Waiver) Approval for a Visiting Professor in the Field of Chemistry (Approval Notice)
General Field: Chemistry Position at the Time of Case Filing: Visiting Professor National Origin: Iran Service Center: Nebraska Service Center (NSC) State Residing at the Time of Filing: California Approval Notice Date: June 17, 2013 Processing Time: 20 weeks
Case Summary:
Chen Immigration Law Associates recently received another NIW approval for a client in the field of chemistry, specializing in the structural analysis of small molecule anti-cancer, carcinogenic, antioxidant and chemopreventative compounds, the structural analysis of lanthanides-biopolymers, and nanomedicine. The success of our client's work has made advancements in the development of natural therapeutic products in the drug industry, and increased the understanding of how antioxidant flavonoids act as cancer therapies. Our client's work has resulted in at least 37 peer-reviewed scientific articles published in leading journals, including 3 review articles, 3 published books, and an invitation to write a chapter for an esteemed publisher. In addition, her publications have been cited at least 363 times according to Scopus, nearly all of which were cited by independent researchers around the world. Her expertise can also be seen in a quote by an independent recommender, “Without her work, the work of other scientists around the globe would suffer, as would the pace of developing new, more efficient treatments for cancers. She is truly an asset to the field and interruption of her work would be a great disservice.” Our client’s tremendous and unique set of skills, knowledge, and diverse background sets her apart from her peers. With the strong petition letter and recommendation letters we prepared, her NIW case was approved in less than five months.

